Beyond Meat Inc
0Q3.DE
€1.057 -1.77%
Exchange: XETRA | Sector: Consumer Defensive | Industry: Packaged Foods
Q4 2024
Published: Mar 5, 2025

Earnings Highlights

  • Revenue of $76.66M down 17.7% year-over-year
  • EPS of $-0.65 decreased by 22.6% from previous year
  • Gross margin of 13.1%
  • Net income of -44.86M
  • "Transcript not provided in the dataset." - Management
0Q3.DE
Company 0Q3.DE

Executive Summary

Beyond Meat reported QQ4 2024 revenue of $76.66 million, down 17.74% year-over-year and 5.37% quarter-over-quarter, signaling continued demand headwinds in a highly competitive plant-based category. The company posted a net loss of $44.86 million and an EPS of -0.65 for the quarter, with gross margins compressing to 13.05% from a higher level in the prior year and prior quarter. Operating performance remained negative, with operating income at -$37.81 million and EBITDA at -$38.17 million, underscoring ongoing fixed-cost absorption and limited operating leverage at this scale.

Liquidity and capital structure present a mixed picture. On the one hand, the balance sheet showed solid liquidity metrics (current ratio 4.66, cash and equivalents ~$131.9 million on balance sheet, and cash per share of $2.03), but the company carries a heavy debt burden (long-term debt ~$1.218 billion; total debt ~$1.222 billion) and negative equity (-$601.21 million). Net debt stood at ~$1.090 billion, and free cash flow was negative at -$35.43 million as of QQ4 2024, driven by negative operating cash flow (-$28.95 million) and modest capital expenditures. The combination of sustained operating losses, high leverage, and negative equity implies ongoing financing and liquidity risks, even as near-term liquidity remains supportive.

From a qualitative standpoint, management commentary (where available) would be critical to confirm plans around cost optimization, manufacturing scalability, and portfolio optimization. While no transcript quotes were provided in the data, the quantitative results point to a need for meaningful gross margin improvement and sharper cash-flow management to restore investor confidence. The external environment remains challenging for plant-based proteins, with margin discipline and go-to-market efficiency likely to drive the path to sustainable profitability. Investors should monitor any forthcoming guidance on cost reduction initiatives, scale benefits from manufacturing improvements, and potential strategic pivots in product mix and pricing.

Key Performance Indicators

Revenue
Decreasing
76.66M
QoQ: -5.37% | YoY: -17.74%
Gross Profit
Decreasing
10.01M
13.05% margin
QoQ: -30.07% | YoY: -27.05%
Operating Income
Decreasing
-37.81M
QoQ: -22.33% | YoY: -11.43%
Net Income
Decreasing
-44.86M
QoQ: -68.81% | YoY: -30.11%
EPS
Decreasing
-0.65
QoQ: -58.54% | YoY: -22.64%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q3 2025 70.22 -1.40 -13.3% View
Q2 2025 74.96 -0.43 -7.5% View
Q1 2025 68.73 -0.69 -26.2% View
Q4 2024 76.66 -0.65 -17.7% View
Q3 2024 81.01 -0.41 +7.2% View